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Abstract
Background: Plasmid mediated quinolone resistant determinants 
(PMQRs) are found to be of clinical relevance because it causes 
decreased susceptibility to quinolones which are valuable antibiotics 
against intrinsically resistant Serratia marcescens. This study aimed 
to determine the occurrence of PMQR determinants (qnr, aac(6′)-Ib-
cr and qep) and their relation with extended-spectrum β-lactamase 
(ESBL) and / or Amp C- producing S. marcescens. 
Material and Method: One hundred and eleven S. marcescens were 
tested for resistance to five quinolones by disc diffusion method. 
Testing for qnr, aac(6′)-Ib-cr and qep was carried out by multiplex 
PCR, while ESBL and Amp C production were evaluated by double 
disc synergy test and cefoxitin Hodge test, respectively. 
Results: A total of 51/111 (45.9%) S. marcescens were resistant to 
one or more of the tested quinolones. Among S. marcescens isolates, 
13 (11.7%) were ESBL producers and 5 (4.5%) were Amp C producers. 
Multiplex PCR confirmed the presence of PMQR determinant in 
14 (12.6%) of S. marcescens isolates and these were positive for qnrA 
and qnr B in 3 and 10 of the isolates, respectively, whereas one isolate 
co- harbored aac(6’)-Ib-cr and qnrA. Among 13 ESBL producers, 3 
and 5 isolates were positive for qnrA and qnr B, respectively (8/13; 
61.5%),whereas one isolate which has co-expressed aac(6’)-Ib-cr and 
qnrA was associated with Amp C production (1/5;20%). 
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Introduction
Serratia marcescens was considered in the past 
to be a harmless and non-pathogenic organism in 
humans, it is now becoming an important cause of 
hospital-associated infections including urinary tract 
infections, respiratory tract infections, septicemia, 
wound infections and meningitis [1]. 
Quinolones are powerful antibacterial agents 
against a wide range of bacteria species causing 
clinical infections [2]. They are particularly valuable 
against infections caused by Gram-negative bacteria 
species such as S. marcescens which is intractable 
to other antibiotics because of its intrinsic resistance 
[1]. 
Plasmid-mediates quinolone resistance (PMQR) 
involves three families, qnrA, qnrB, and qnrS 
[3]. The presence of these enzymes is of great 
importance because they are not merely able to 
confer resistance against most available quinolones 
but as well are often related to extended-spectrum 
β-lactamases (ESBLs) and/or plasmid-mediated Amp 
C β-lactamases (pAmp Cs) [4]. Six determinants of 
QnrA has been recorded worldwide from different 
enterobacterial species. This gene codes for a 218 
amino acid protein of the pentapeptide family 
that prevent binding of quinolone to gyrase and 
topoisomerase IV protecting DNA [5]. Two other 
PMQR genes, called, qnrB and qnrS, have been 
recognized that code for QnrB and QnrS and share 
41% and 60% amino acid homology with QnrA, 
respectively [6]. 
Another mechanism of conjugal quinolone 
resistance via an enzymatic inactivation of 
some quinolones by means of aminoglycoside 
acetyltransferase that codes for cr variant of aac(6′)-
Ib was detected. It acts by N-acetylation of their 
piperazinyl amine causing decreased susceptibility 
to quinolone. They have the same mechanism of 
action like QnrA [7]. 
Lastly, the extra PMQR determinants is the 
quinolone efflux pump gene, qepA. It shared a 
substantial resemblance to the major facilitator 
superfamily-type efflux pumps. This protein cause 
reduced susceptibility to many quinolones [8]. 
This study was conducted to find out the rate 
of PMQR determinants (qnr, aac(6′)-Ib-cr and qep) 
in S. marcescens isolated from hospitalized patients 
at the Mansoura University Hospitals and their 
association with extended-spectrum β-lactamase 
(ESBL) and / or Amp C- producing S. marcescens.
Material and methods
Study design
This prospective study was carried out over 
a period of 6 years from January 2008 through 
January 2014, where S. marcescens strains were 
isolated from various clinical samples obtained 
from patients at the Mansoura University Hospitals 
(MUHs), Mansoura, Egypt. The samples processing 
were carried out in diagnostics and infection control 
unit (MDICU). 
Conclusion: This study indicated that PMQRS play significant role 
in the occurrence and expansion of fluoroquinolone resistance in 
S. macrscens. They are also associated with ESBL and Amp C producers 
and important cause of infections in hospitalized patients. 
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 All samples were cultured on Blood and 
MacConkey’s agar. Identification of S. marcescens 
isolates to species level was done primarily by Gram 
stain, colonial morphology, biochemical reactions 
including indole, methyl red, voges proskauer and 
citrate test (IMVC), motility on semisolid agar, 
DNAase, gelatin liquefaction tests and confirmed 
later with API 20E (bioMérieux) [9]. 
All isolates were tested for antibiotic susceptibility 
by disc diffusion method according to CLSI guidelines 
[10]. The isolates were tested against amoxicillin/
clavulanic acid (20/10 μg), ceftazidime (30 µg), 
cefepime (30 µg), imipenem (10µg), gentamicin 
(10µg), trimethoprim/sulfamethoxazole (25 µg), 
norfloxacin (10µg), nalidxic (30µg), ofloxacin (5 µg) 
ciprofloxacin(5 µg) and levofloxacin (5 µg) (Oxoid, 
UK). All isolates showed intermediate susceptibility 
were considered as resistant strains. 
ESBL detection was detected by the use of a 
double-disk synergy test, and a test was considered 
positive if any distortion or zone increase towards 
the disc of amoxicillin-clavulanate was detected as 
reported by Paterson and Bonomo [11]. 
The cefoxitin Hodge test was used to screen 
strains producing Amp C β-lactamase and the test 
was interpreted positive in case of the presence 
of clear growth of the control strain (ATCC E. coli 
25922) along with the test isolate within the 22 mm 




Quick DNA extraction was done by a boiling 
technique that consists of a heating at 100o C of one 
colony in a volume of 100 µL of distilled water for 5 
minutes then centrifugation of the cell suspension. 
Multiplex PCR amplification of qnrA, qnrB, and 
qnrS was carried out according to Robicseket al 
2006. Primer sets used are listed in table (1) 
[13]. All primers were added to the template 
DNA and PCR master mix (Fermentas). The 
cycling conditions used were 94°C for 45 s 
(denaturation), 53°C for 45 s (annealing), and 
72°C for 60 s (extension), which was repeated for 
32 cycles. Another multiplex of PCR was held for 
amplification of aac(6′)-Ib and qep with sequence 
of primers [14] mentioned as presented in Table 
(1). PCR conditions were 94°C for 45 s, 55°C for 
45 s, and 72°C for 45 s for 34 cycles. All positive 
PCR products for aac(6′)-Ib were subsequently 
analyzed by digestion with BtsCI (Thermo Fisher 
Table 1. Primers for amplification of PMQR molecular determinants





qnrA FW5′-ATTTCTCACGCCAGGATTTG-3′  DW5′-GATCGGCAAAGGTTAGGTCA-3′ 516 13
qnrB FW5-′GATCGTGAAAGCCAGAAAGG-3′ DW5′-ACGATGCCTGGTAGTTGTCC-3′ 469 13
qnrS FW5′-ACGACATTCGTCAACTGCAA-3′ DW5-TAAATTGGCACCCTGTAGGC-3′ 417 13
aac(6′)-Ib FW5-TTGCGATGCTCTATGAGTGGCTA-3′DW5′-CTCGAATGCCTGGCGTGTTT-3′ 482 14
qep FW5′- AACTGCTTGAGCCCGTAGAT -3′ DW 5- GTCTACGCCATGGACCTCAC-3′ 596 14
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Scientific™) to detect aac(6′)-Ib-cr, that is deficient 
in the BtsCI restriction site found in the wild-type 
gene. The wild-type aac(6′)-Ib PCR gave 210-
bp and 272-bp fragments after restriction [15]. 
Amplification products were identified by their 
sizes in 2% ethidium bromide-stained agarose 
gels using 50bp DNA as control marker.
Statistical Analysis
Chi-square analysis was done to verify correlation 
between PMQR determinants and ESBl and Amp C 
producers. All statistical analyses were performed 
using Statistical Package for Social Science program 
(SPSS version 15.0 for windows, Chicago, IL). P≤ 
0.05 was considered statistically significant. 
Results
A total of 111 S. marcescens isolates were 
isolated from various clinical specimens. These 
isolates were obtained from the respiratory 
tract (69.6%), wounds (8.7%), blood (5.8%), 
urine (2.9%), body fluids (3.9%), and the rest 
(9.1%) from other body sites. Resistance to one 
or more of the used quinolone was detected in 
51/111(45.9%) of S. marcescens isolates. Among 
the isolated S. marcescens, 13 (11.7) isolates showed 
enhancement of the inhibitory zones of ceftazadime 
by clavulanic acid, signifying the existence of 
ESBL activity, while 5 had a positive results for 
amp C (4.5%) production using the cefoxitin 
Hodge test. No isolates showed combined ESBL 
and Amp C production. S.  marcescens harbored 
qnr determinants in 14 isolates (12.6%). The qnr 
types, qnrA and qnr B genes were detected in 3 
and 10 isolates, respectively, whereas one isolate 
co-expressed aac(6’)-Ib-cr and qnrA. None of the 
isolates expressed qep gene. All detected PMQR 
gene determinants were quinolone resistant (14/ 
51; 27.5%). Among ESBL producers, 3 and 5 isolates 
harbored qnrA and qnr B genes, respectively. 
While one isolate co- harbored aac(6’)-Ib-cr and 
qnrA and was Amp C producers (1/5; 20%). The 
occurrence of PMQR genes was more frequent 
among ESBL S. marcescens (8 /13; 61.5%) than 
in non-ESBL producers (6/ 98; 6.1%) (p < 0.05). 
Table 2.  Distribution of PMQR among S. marcescens ESBL and non ESBL producers
PMQR genes
N. (%)
S. marcescens ESBL producers 
non Ampc producers
N. (%) 
S. marcescens non ESBL 
producers
Total  
N. (%) S. marcescens
13 (11.7) 98(88.3) 111 (100)
qnrA 3(37.5) 0 (0) 3 (2.7)
qnr B 5(62.5) 5 ( 5.1) 10(9)
qnr S 0 (0) 0(0) 0(0)
qnrA+ aac(6’)-Ib-cr 0 (0) 1 (1) 1(0.9)
qep 0(0) 0 (0) 0(0)
Total PMQR 8 (61.5) 6 (6.1) 14 (12.6)
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S.marcescens non Amp C 
producers
S. marcescens




  N. (%)
111 (100)
qnrA 0 (0) 3 (2.8) 3 (2.7)
qnr B 0(0) 10 ( 9.4) 10(9)
qnr S 0(0) 0(0) 0(0)
qnrA+ aac(6’)-Ib-cr 1(20) 0 (0) 1(0.9)
qep 0(0) 0 (0) 0(0)
Total no. (%) 1(20) 13(12.3) 14 (12.6)
Table 4.  Frequency of Quinolone resistance and PMQR determinants along with their types among isolated 
Serratia marcescens over 6 years.
year








Total n. (%) 
S.marcescens / year
2008 – 2009 2 (18.2) Null - 11 (100)
2009 – 2010 5 (22.7) Null - 22 (100)
2010 – 2011 5 (31.3) 1 (6.3) qnr B 16 (100)
2011 -2012 11 (45.8) 3 (12.5) 2qnr B, 1 qnr A 24 (100)
2012- 2013 13 (65%) 4 (20) 4 qnr B 20 (100)
2013 – 2014 15 (83.3) 6 (33.3)
3 qnr B, 2 qnr A, 1 
combined qnr A and 
aac(6’)-Ib-cr 
18 (100%)
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(Table 2) No statistical significance was observed 
regarding PMQR among S. marcescens Amp C 
(1/ 5; 20%) and non Amp C producers (13/ 106, 
12.3%) (p > 0.05). (Table 3) Over the six years 
study period the overall frequency of PMQR gene 
determinants together with quinolone resistance 
have progressively increased by time. (Table 4).
Discussion
This study has detected quinolone resistance at 
a rate of 45.9%, whereas a study by Park et al. 
in USA [16], found a higher rate of resistance to 
quinolones (66.3%), and the study of Yang et al. 
in China [17], reported much lower results (10.3%). 
The overall frequency of PMQR genes among the S. 
marcescens isolates in our study was 12.6% which is 
similar to other recent study that carried in China [3], 
while the study of Park et al. [16], on the contrary 
has showed much lower frequency (2.4%). 
The present study demonstrates that the quinolone 
resistance was increased over time together with 
a growing shift to PMQR molecular determinants. 
This increase may be attributed to performance 
and enhancement of selection pressure of resistant 
mutants especially with extensive use of quinolones 
over the study period. In addition, further increase in 
the magnitude of the problem could be supported 
by the hypothesis that PMQR encourage emergence 
of QRDR mutations in gyrA and parC associated 
with quinolone resistance [14,17]. 
This study shows that qnrB is the most dominant 
(71.4%) among PMQR genes, ant it is similar to 
many other studies over the world [6,7,18-21]. 
Moreover, this gene was the most common among 
ESBL producers signifying the relation between this 
gene and other resistance genes as observed by 
other researchers [22-25]. In contrast to the current 
results, the data reported by Yang et al. [3], found 
that the aac(6′)-Ib-cr gene was the most prevalent 
among S. marcescens ESBL producers. Additionally, 
Robicsek et al. [7], found this gene to be the most 
common in E. coli and the reason of this finding 
could not be explained. However, a different 
geographic distribution could be suggested as a 
cause for this variation. It is noted that aac(6’)-Ib-cr 
and qnrA were co-expressed in one of our isolates, 
This finding support other reported results where 
some plasmids can carry both aac(6′)-Ib-cr and qnrA 
[14]. This association confers the superior level of 
resistance to quinolones than do each gene by itself, 
although other studies found no relation between 
qnr genes and aac(6′)-Ib-cr gene [7,26]. 
The frequency of the PMQR determinants in ESBL 
producing S. marcescens isolated from hospitals in 
this study was 61.5%., while a study done in Korea 
has detected only 4.8% as qnr-positive among ESBL 
producing S. marcescens strains [16]. However, high 
incidence (71.4%) has also been found in China [3]. 
A low incidence of qnr genes was detected among 
ESBL producing isolates of E. coli and Klebsiella spp. 
in France and Canada(1.6% and 1%, respectively), 
whereas high frequency of the qnr genes was 
reported in Egypt (26.6%) among ESBL producing 
E.coli [26], and in Spain, this prevalence was found 
among ESBL producing E.coli and Klebsiella at 5% 
and 8%, respectively [27]. 
Although our study has not detected any 
statistically significant results regarding the presence 
of PMQR determinants in association with pAmpCs 
(20%), it is still important to report that PMQR genes 
are frequently linked to ESBLs and/or pAmpCs and 
they can be transferred by conjugation [3]. 
The high frequency of PMQR among ESBL and 
Amp C producers in this study could be attributed 
to the genetic linkage and horizontal transfer of 
these resistance genes on plasmids [4].
In conclusion, quinolones are important drugs 
used in the treatment of infections caused by S. 
marcescens. Therefore, the increased frequency of 
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PMQRs among this organism over 6-year signifies 
a real therapeutic problem. Moreover, the close 
association between PMQR, ESBLs and Amp C genes 
in this organism would cause failure of treatment. 
This study recommends continuous surveillance to 
detect and molecular characterization of resistant 
bacteria isolates in hospitalized patients. 
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